-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Cti Biopharma Corp quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q1 2023.
- Cti Biopharma Corp Cost of Revenue for the quarter ending March 31, 2023 was $1.22M, a 340% increase year-over-year.
- Cti Biopharma Corp Cost of Revenue for the twelve months ending March 31, 2023 was $4.46M, a 1504% increase year-over-year.
- Cti Biopharma Corp annual Cost of Revenue for 2022 was $3.51M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)